- AU$8.58bn
- AU$8.60bn
- AU$2.35bn
Annual income statement for Cochlear, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,648 | 1,936 | 2,236 | 2,343 | 2,348 |
| Cost of Revenue | |||||
| Gross Profit | 1,237 | 1,448 | 1,674 | 1,728 | 1,660 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,248 | 1,547 | 1,761 | 1,825 | 2,131 |
| Operating Profit | 400 | 390 | 475 | 518 | 217 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 394 | 397 | 485 | 519 | 214 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 289 | 301 | 357 | 389 | 147 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 289 | 301 | 357 | 389 | 147 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 289 | 301 | 357 | 389 | 147 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.38 | 4.56 | 5.74 | 5.93 | 3.24 |
| Dividends per Share |